Xeloda® is a highly active oral fluoropyrimidine designed to generate the active drug 5-fluorouracil (5-FU) preferentially in tumour tissue...
More information
Check here the Xeloda® (capecitabine) mode of action in detail.
Xeloda® (capecitabina) monotherapy is well tolerated. The majority of treatment-related adverse events are mild or moderate in intensity...
To know the indication and treatment regimens with Xeloda® (capecitabine) click next.